Adiponectin: An Indicator for Metabolic Syndrome
Background: Metabolic syndrome (MetS), a cluster of cardiometabolic risk factors, consider as a manifestation of obesity. However, a proportion of obese patients do not develop MetS. The aim of our study was to determine whether concentration of plasma adiponectin and leptin differ between metabolic...
Saved in:
Main Authors: | Somaye YOSAEE (Author), Mahmoud KHODADOST (Author), Alireza ESTEGHAMATI (Author), John R. SPEAKMAN (Author), Kurosh DJAFARIAN (Author), Vida BITARAFAN (Author), Farzad SHIDFAR (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New advances of adiponectin in regulating obesity and related metabolic syndromes
by: Yanqi Han, et al.
Published: (2024) -
Unsuccessful Weight-Loss in Adults Admitted to Health Centers, Ahvaz, Khuzestan: A Phenomenological Study
by: Farzad Faraji Khiavi, et al.
Published: (2020) -
Comparison of urinary adiponectin in the presence of metabolic syndrome in peri- and postmenopausal women
by: Patsama Vichinsartvichai, et al.
Published: (2022) -
Adiponectin and lipid metabolism in skeletal muscle
by: Bonggi Lee, et al.
Published: (2012) -
Adiponectin serenades ceramidase to improve metabolism
by: Saskia Reibe-Pal, et al.
Published: (2017)